The primary treatment modality for patients with carcinoma of the esophagus or gastroesophageal junction has been surgery, although primary radiation therapy with concurrent chemotherapy produces similar results. As both have curative potential, there has been great interest in the use of trimodality therapy. To this end, we compared survival, response, and patterns of failure of trimodality therapy to esophagectomy alone in patients with nonmetastatic esophageal cancer
Background: While neoadjuvant chemoradiation therapy (nCRT) with subsequent surgery is the treatment...
Background: Standard therapy for loco-regionally advanced, resectable oesophageal carcinoma is trimo...
Background: The optimum curative approach to adenocarcinoma of the oesophagus and oesophagogastric j...
Objectives: It was the aim of this study to assess our institutional experience with definitive chem...
Objectives: Patients with stage II and III esophageal cancer are often incurable with surgery alone,...
Background: Trimodality therapy (TMT) with neoadjuvant chemoradiotherapy (nCRT) using concurrent car...
BACKGROUND A Phase II trial was conducted at the University of Michigan to determine the efficacy o...
BACKGROUND: Resection remains the best treatment for carcinoma of the oesophagus in terms of local c...
Abstract- Despite all advances, treatment of esophageal carcinoma is still unsatisfactory. Currently...
Background: The treatment of esophageal carcinoma may demand multiple approaches including combinati...
Purpose: This report updates local control and survival experience and focuses on treatment toxicity...
Background:Cisplatin-based chemoradiotherapy (CRT) has been a standard treatment for patients with l...
Introduction: Esophageal cancer is the seventh most frequent malignancy in Iranian men and the fourt...
Purpose: To determine whether CR-S improves survival for resectable cancer of the esophagus. Method:...
textabstractBACKGROUND: The role of neoadjuvant chemoradiotherapy in the treatment of patients with ...
Background: While neoadjuvant chemoradiation therapy (nCRT) with subsequent surgery is the treatment...
Background: Standard therapy for loco-regionally advanced, resectable oesophageal carcinoma is trimo...
Background: The optimum curative approach to adenocarcinoma of the oesophagus and oesophagogastric j...
Objectives: It was the aim of this study to assess our institutional experience with definitive chem...
Objectives: Patients with stage II and III esophageal cancer are often incurable with surgery alone,...
Background: Trimodality therapy (TMT) with neoadjuvant chemoradiotherapy (nCRT) using concurrent car...
BACKGROUND A Phase II trial was conducted at the University of Michigan to determine the efficacy o...
BACKGROUND: Resection remains the best treatment for carcinoma of the oesophagus in terms of local c...
Abstract- Despite all advances, treatment of esophageal carcinoma is still unsatisfactory. Currently...
Background: The treatment of esophageal carcinoma may demand multiple approaches including combinati...
Purpose: This report updates local control and survival experience and focuses on treatment toxicity...
Background:Cisplatin-based chemoradiotherapy (CRT) has been a standard treatment for patients with l...
Introduction: Esophageal cancer is the seventh most frequent malignancy in Iranian men and the fourt...
Purpose: To determine whether CR-S improves survival for resectable cancer of the esophagus. Method:...
textabstractBACKGROUND: The role of neoadjuvant chemoradiotherapy in the treatment of patients with ...
Background: While neoadjuvant chemoradiation therapy (nCRT) with subsequent surgery is the treatment...
Background: Standard therapy for loco-regionally advanced, resectable oesophageal carcinoma is trimo...
Background: The optimum curative approach to adenocarcinoma of the oesophagus and oesophagogastric j...